Nothing Special   »   [go: up one dir, main page]

Meenatchisundaram et al., 2008 - Google Patents

Neutralization of the pharmacological effects of Cobra and Krait venoms by chicken egg yolk antibodies

Meenatchisundaram et al., 2008

View PDF
Document ID
9746285229723365294
Author
Meenatchisundaram S
Parameswari G
Michael A
Ramalingam S
Publication year
Publication venue
Toxicon

External Links

Snippet

Five-month-old white leghorn chickens were immunized with 50μg of Common Cobra (Naja naja) and 30μg of Krait venoms (Bungarus caeruleus) to generate antivenom antibodies against the venom antigen. Chickens received booster doses of increasing concentrations of …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Meenatchisundaram et al. Neutralization of the pharmacological effects of Cobra and Krait venoms by chicken egg yolk antibodies
Chippaux et al. Venoms, antivenoms and immunotherapy
Brunda et al. Use of egg yolk antibody (IgY) as an immunoanalytical tool in the detection of Indian cobra (Naja naja naja) venom in biological samples of forensic origin
de Almeida et al. Development of process to produce polyvalent IgY antibodies anti-African snake venom
Figueiredo et al. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses
Guilherme et al. Neutralization of dermonecrotic and lethal activities and differences among 32–35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies
Alvarenga et al. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay
Redwan et al. Simple and efficient protocol for immunoglobulin Y purification from chicken egg yolk
Morokuma et al. Experimental manufacture of equine antivenom againt Yamakagashi (Rhabdophis tigrinus)
Meenatchisundaram et al. Antitoxin activity of Mimosa pudica root extracts against Naja naja and Bangarus caerulus venoms
Meenatchisundaram et al. Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies
Maria et al. Neutralizing potency of horse antibothropic antivenom. Correlation between in vivo and in vitro methods
Sapsutthipas et al. Effective equine immunization protocol for production of potent poly-specific antisera against Calloselasma rhodostoma, Cryptelytrops albolabris and Daboia siamensis
Zolfagharian et al. Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization
Navarro et al. Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom
Arguedas et al. Comparison of adjuvant emulsions for their safety and ability to enhance the antibody response in horses immunized with African snake venoms
Kuniyoshi et al. Experimental antivenom against serine proteases from the Bothrops jararaca venom obtained in mice, and its comparison with the antibothropic serum from the Butantan Institute
Ponce-López et al. Neutralizing potency and immunochemical evaluation of an anti-Crotalus mictlantecuhtli experimental serum
Milovanović et al. Application of the 3R concept in the production of European antiviperinum on horses–Multisite, low volumes immunization protocol and ELISA
Devi et al. Development of viper-venom antibodies in chicken egg yolk and assay of their antigen binding capacity
Guidolin et al. Characterization of anti-crotalic antibodies
Dias da Silva et al. The humoral immune response induced by snake venom toxins
Ozkan et al. The neutralizing capacity of Androctonus crassicauda antivenom against Mesobuthus eupeus scorpion venom
Maria de Fátima et al. Antigenic cross-reactivity and immunogenicity of Bothrops venoms from snakes of the Amazon region
Choraria et al. Chicken egg yolk antibodies (IgY)-based antivenom for neutralization of snake venoms: a review